$54.99
This item has been third-party tested by accredited U.S. laboratories and confirmed to meet a minimum purity of 98% through rigorous verification standards.
Updated COA's
Secure Shipping Guaranteed
Verified for Purity
$54.99
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.
So, what is Ipamorelin? It’s a unique pentapeptide composed of five amino acids and belongs to the growth hormone-releasing peptide (GHRP) family. It has recently emerged as a compound of considerable interest for its potential to stimulate growth hormone (GH) secretion and associated physiological effects in research. As a selective growth hormone secretagogue (GHS), ipamorelin binds to specific receptors on somatotropes, stimulating GH release through intracellular signaling pathways.
This peptide works by mimicking ghrelin (the hunger hormone), which stimulates the pituitary gland to release more growth hormone into the bloodstream. Ipaomrelion shares similarities with other GHPRs such as GHRP 6 and GHRP 2 in mechanism of action—essentially how they work within the body.
This peptide is selective—it doesn’t lead to an excessive surge of cortisol release or follicle-stimulating hormone like some other GHRPs do. This selectivity makes sure that increased HGH is not offset by any undesirable hormonal changes.
Unlike many other GHS, ipamorelin does not induce substantial increases in cortisol, prolactin, or aldosterone at studied amounts, highlighting its specificity for GH stimulation. Research suggests that it can increase GH secretion, resulting in alterations in muscle growth, body composition, and metabolic function.
Specifically, clinical studies have shown that ipamorelin can increase lean body mass and reduce fat mass in both healthy individuals and those with GH deficiency. There is evidence that it can improve bone mineral density along with muscle accretion. At the metabolic level, ipamorelin has been shown to increase insulin sensitivity and glucose utilization in normal and diabetic rats. Preliminary research also suggests that ipamorelin may have anti-aging effects by promoting collagen production and skin elasticity through extracellular matrix remodeling.
Ipamorelin’s growth-promoting and metabolic effects will require continued investigation but highlight its substantial relevance in the field of peptides. Further research is needed to validate and replicate these preliminary findings.
Improved sleep and increased libido are effects being studied with Ipamorelin. Better sleep quality, in particular, is crucial for overall wellness and recovery, especially for individuals engaged in regular physical activity.
Improved control over blood glucose could help reduce the risk factors associated with developing type 2 diabetes. As such, some scientists believe that chemicals like Ipamorelin might offer preventative measures.
Several studies have shown that peptides like Ipamorelin may increase insulin secretion. When insulin production or utilization is impaired, as with type 2 diabetes, glucose accumulates in the bloodstream instead of being metabolized by cells. If the body’s ability to secrete more insulin, using compounds like Ipamorelin, can be enhanced, subjects can better manage their blood sugar levels.
There’s mention of Ipamorelin aiding with inflammatory issues in research, but more experimentation must be completed.
While these findings are exciting and promising, research on ipamorelin and diabetes is relatively new. The potential role in insulin release and type 2 diabetes requires further study to confirm these effects.
By purchasing from ResearchChemical.com, you acknowledge and agree that you are acquiring Research Chemicals. These chemical substances are specifically designed for utilization in scientific and medical research endeavors.
It is essential to note that these research chemicals are intended exclusively for laboratory use. They are not sold for consumer use.
Please be advised that the statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Furthermore, the products offered by this company are not intended to diagnose, treat, cure, or prevent any disease.
The information provided on this website is solely for informational and educational purposes and should not be considered as medical advice or a substitute for professional medical guidance.
ResearchChemical.com, its manufacturers, sellers, and distributors hold no liability for any consequences arising from the misuse, improper handling, or usage of these chemicals. Please be aware that the sale and purchase of these chemicals may be subject to legal restrictions and regulations in some jurisdictions. It is the buyer’s responsibility to ensure compliance with all applicable laws and regulations.
1. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective GH secretagogue. European Journal of Endocrinology. 1998 Oct;139(5):552-61. doi: 10.1530/eje.0.1390552.
2. Johansen, P. B., Nowak, J., Skjærbæk, C., Flyvbjerg, A., Andreassen, T. T., Wilken, M., & Ørskov, H. (1999). Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone & IGF Research, 9(2), 106-113.
3. Vahl, N., Juul, A., Jørgensen, J. O., Ørskov, H., Skakkebæk, N. E., & Christiansen, J. S. (2000). Continuation of GH replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. The Journal of Clinical Endocrinology & Metabolism, 85(5), 1874-1881.
4. Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., … & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of GH secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149.
5. Horvath, T. L., Castañeda, T., Tang-Christensen, M., Pagotto, U., & Tschop, M. H. (2003). Ghrelin as a potential anti-obesity target. Current Pharmaceutical Design, 9(17), 1383-1395.
6. Sjögren, K., Jansson, J. O., Isaksson, O. G., & Ohlsson, C. (2002). A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I. Endocrine, 19, 249-256.
7. D’Agostino, P. IGF-1 LR3: The rapid-acting GH alternative.
8. Ishida, J., Saitoh, M., Ebner, N., Springer, J., Anker, S. D., & von Haehling, S. (2020). Growth hormone secretagogues: history, mechanism of action, and clinical development. JCSM Rapid Communications, 3(1), 25-37.
9. Adeghate, E., & Ponery, A. S. (2004). Mechanism of ipamorelin-evoked insulin release from the pancreas of normal and diabetic rats. Neuroendocrinology Letters, 25(6), 403-406.
10. Andersen, N. B., Malmlöf, K., Johansen, P. B., Andreassen, T. T., Ørtoft, G., & Oxlund, H. (2001). The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth Hormone & IGF Research, 11(5), 266-272.
Please note that the above references provide evidence for the potential benefits of Ipamorelin Peptide as stated in the product description. For more in-depth information, refer to these scholarly works.
Ipamorelin is a growth hormone secretagogue that stimulates the release of GH from the pituitary gland. It has potential implications in promoting overall growth, bone formation, and lean muscle mass, but further research must be conducted to confirm these preliminary findings.
Yes, the ghrelin mimetic ipamorelin is known to increase GH levels and stimulate growth hormone release from the pituitary gland.
Research suggests that the growth hormone releasing hormone ipamorelin may have a favorable safety profile, as it is well-tolerated in laboratory and research use. However, more comprehensive clinical trials are needed to ascertain any potential negative side effects.
According to recent research, Ipamorelin’s operational mechanics enable it to increase GH levels, which may support body weight regulation and promote lean muscle tissue, contributing to potential weight loss.
If you are searching for where to buy Ipamorelin online, you will come across many options. Several companies offer peptides, but unfortunately, not all prioritize quality assurance.
Research Chemical stands out in this landscape. We’re committed to delivering only the finest Ipamorelin for sale online. When you decide to buy peptides from us, rest assured, you’re opting for top-tier quality.
Our peptides undergo rigorous testing, verified by esteemed American third-party laboratories—labs that welcome phone or email inquiries to confirm their certificate’s authenticity. Our peptides for sale are preserved in lyophilized form inside glass containers and maintained in cool conditions to uphold their potency.
You can trust in our assortment of top-grade research chemicals, all backed by a reassuring 60-day money-back guarantee. Plus, enjoy free shipping for orders over $149, with expedited shipping options available. Subscribers to our newsletter enjoy a 10% discount, and choosing cryptocurrency for payment affords an additional 10% off.
Choose Research Chemical, and you’re not just selecting a seller; you’re opting for verified excellence, secured packaging, prompt deliveries, and exemplary customer service. For any queries about our Ipamorelin for sale or any other product, don’t hesitate to contact us. We’re here to assist promptly.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
This peptide works by mimicking ghrelin (the hunger hormone), which stimulates the pituitary gland to release more growth hormone into the bloodstream. Ipaomrelion shares similarities with other GHPRs such as GHRP 6 and GHRP 2 in mechanism of action—essentially how they work within the body.
This peptide is selective—it doesn’t lead to an excessive surge of cortisol release or follicle-stimulating hormone like some other GHRPs do. This selectivity makes sure that increased HGH is not offset by any undesirable hormonal changes.
By purchasing from ResearchChemical.com, you acknowledge and agree that you are acquiring Research Chemicals. These chemical substances are specifically designed for utilization in scientific and medical research endeavors.
It is essential to note that these research chemicals are intended exclusively for laboratory use. They are not sold for consumer use.
Please be advised that the statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Furthermore, the products offered by this company are not intended to diagnose, treat, cure, or prevent any disease.
The information provided on this website is solely for informational and educational purposes and should not be considered as medical advice or a substitute for professional medical guidance.
ResearchChemical.com, its manufacturers, sellers, and distributors hold no liability for any consequences arising from the misuse, improper handling, or usage of these chemicals. Please be aware that the sale and purchase of these chemicals may be subject to legal restrictions and regulations in some jurisdictions. It is the buyer’s responsibility to ensure compliance with all applicable laws and regulations.
1. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective GH secretagogue. European Journal of Endocrinology. 1998 Oct;139(5):552-61. doi: 10.1530/eje.0.1390552.
2. Johansen, P. B., Nowak, J., Skjærbæk, C., Flyvbjerg, A., Andreassen, T. T., Wilken, M., & Ørskov, H. (1999). Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone & IGF Research, 9(2), 106-113.
3. Vahl, N., Juul, A., Jørgensen, J. O., Ørskov, H., Skakkebæk, N. E., & Christiansen, J. S. (2000). Continuation of GH replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. The Journal of Clinical Endocrinology & Metabolism, 85(5), 1874-1881.
4. Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., … & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of GH secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149.
5. Horvath, T. L., Castañeda, T., Tang-Christensen, M., Pagotto, U., & Tschop, M. H. (2003). Ghrelin as a potential anti-obesity target. Current Pharmaceutical Design, 9(17), 1383-1395.
6. Sjögren, K., Jansson, J. O., Isaksson, O. G., & Ohlsson, C. (2002). A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I. Endocrine, 19, 249-256.
7. D’Agostino, P. IGF-1 LR3: The rapid-acting GH alternative.
8. Ishida, J., Saitoh, M., Ebner, N., Springer, J., Anker, S. D., & von Haehling, S. (2020). Growth hormone secretagogues: history, mechanism of action, and clinical development. JCSM Rapid Communications, 3(1), 25-37.
9. Adeghate, E., & Ponery, A. S. (2004). Mechanism of ipamorelin-evoked insulin release from the pancreas of normal and diabetic rats. Neuroendocrinology Letters, 25(6), 403-406.
10. Andersen, N. B., Malmlöf, K., Johansen, P. B., Andreassen, T. T., Ørtoft, G., & Oxlund, H. (2001). The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth Hormone & IGF Research, 11(5), 266-272.
Please note that the above references provide evidence for the potential benefits of Ipamorelin Peptide as stated in the product description. For more in-depth information, refer to these scholarly works.
Join our insider list for the latest research insights, product releases, and special offers—delivered straight to your inbox.
